Radiotherapy physics research in the UK: challenges and proposed solutions.
暂无分享,去创建一个
R. Mackay | J. Staffurth | T. Illidge | N. Burnet | S. Green
[1] R Jeraj,et al. The physical basis and future of radiation therapy. , 2011, The British journal of radiology.
[2] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[3] W.P.M. Mayles. Survey of the availability and use of advanced radiotherapy technology in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[4] R. Plummer,et al. Radiotherapy research priorities for the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[5] Brian O'Sullivan,et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Tim Maughan. A new opportunity for radiotherapy research in the UK. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] J. Yarnold,et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.
[8] J R Yarnold,et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.
[9] M. Parmar,et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. , 2007, The Lancet. Oncology.
[10] T. Evans. Best research for best health: a new national health research strategy. , 2006, Clinical medicine.
[11] B. Slotman,et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] D. Dearnaley,et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.
[13] M. Parmar,et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.
[14] G. Kerr,et al. Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial. , 1990, BMJ.
[15] Annie Gao,et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. , 2012, The Lancet. Oncology.
[16] J. Yarnold,et al. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. , 2011, International journal of radiation oncology, biology, physics.
[17] J. Yarnold,et al. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.